Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*
2005
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
Prospects for Cardiovascular Research
2001 StandoutNobel
Atopic dermatitis
2015 Standout
Valsartan in heart failure patients previously untreated with an ACE inhibitor
1998
Acute Cardiac Tamponade
2003 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus
2007
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
2001
The Prognostic Value of Big Endothelin-1 in More Than 2,300 Patients With Heart Failure Enrolled in the Valsartan Heart Failure Trial (Val-HeFT)
2006
Basic mechanisms in heart failure: The cytokine hypothesis
1996
Type 2 diabetes as an inflammatory disease
2011 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Acute Renal Failure
1996 Standout
Hormones and Hemodynamics in Heart Failure
1999
Successes and failures of current treatment of heart failure
1998
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003 Standout
Endothelin antagonists
1999
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
2014
How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?
2003
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Type 2 diabetes
2017 Standout
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
2001 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
How were new medicines discovered?
2011 Standout
Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure
1998
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene
2005 StandoutNobel
Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
1999
Phosphorylation and Desensitization of Human Endothelin A and B Receptors
1997 StandoutNobel
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure
1998
Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy
2003
Congestive Heart Failure: Fifty Years of Progress
2000
New therapeutics that antagonize endothelin: promises and frustrations
2002
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Endothelins
1995
Right ventricular cardiomyopathy in β-thalassaemia major
2002
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Biomarkers in Heart Failure
2008 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
2004
Prognostic value of serial B‐type natriuretic peptide measurement in asymptomatic organic mitral regurgitation
2010
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
1999 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Amylin Agonists: A Novel Approach in the Treatment of Diabetes
2004
Short-Term Oral Endothelin-Receptor Antagonist Therapy in Conventionally Treated Patients With Symptomatic Severe Chronic Heart Failure
1998
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Diabetes and Cancer
2010 Standout
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
2001 Standout
Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin
1998
Endothelial dysfunction in essential hypertension: clinical implications
2002
Endothelin Receptor Blockers in Cardiovascular Disease
2003
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Human aging is associated with parallel reductions in insulin and amylin release
1998
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Mechanisms of Diabetic Complications
2013 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
Works of M. Schüller being referenced
Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension
1993
Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
1996
Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
1994
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure
1996
Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure
1997
Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans
1991
Radioimmunoassay of immunoreactive C-terminal big-endothelin(22-38).
1991
Age‐related changes in the composition of the cornified envelope in human skin
2013